Provided by Tiger Trade Technology Pte. Ltd.

Lyell Immunopharma, Inc.

10.74
-0.1700-1.56%
Volume:54.08K
Turnover:587.32K
Market Cap:263.18M
PE:-0.91
High:10.98
Open:10.91
Low:10.72
Close:10.91
52wk High:45.00
52wk Low:10.55
Shares:24.50M
Float Shares:10.79M
Volume Ratio:0.98
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.8281
EPS(LYR):-16.0562
ROE:-93.28%
ROA:-34.18%
PB:1.13
PE(LYR):-0.67

Loading ...

Lyell Immunopharma Management to Join Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 14

Lyell Immunopharma Price Target Maintained with a $44.00/Share by Needham

Dow Jones
·
Sep 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 11

Lyell Immunopharma CMO Jarrad Mattieu Aguirre Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Lyell Immunopharma advances LYL273 CAR T program

TIPRANKS
·
Sep 11

Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial

Reuters
·
Sep 11

Lyell Immunopharma, - Additional Clinical Data and End-of-Phase 1 FDA Meeting Expected in 2027

THOMSON REUTERS
·
Sep 11

Lyell Immunopharma Completes Manufacturing Transfer for Lyl273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer

THOMSON REUTERS
·
Sep 11

This Insider Has Just Sold Shares In Lyell Immunopharma

Simply Wall St.
·
Aug 27

Bank of America Securities Remains a Sell on Lyell Immunopharma (LYEL)

TIPRANKS
·
Aug 11

Lyell Immunopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Lyell Immunopharma, Inc. Expected to Post a Loss of $2.08 a Share - Earnings Preview

Reuters
·
Aug 08

Analysts’ Top Healthcare Picks: Lyell Immunopharma (LYEL), Janux Therapeutics Inc (JANX)

TIPRANKS
·
Aug 07

Lyell Net Loss Widens to $44.76 Million in Q2 FY26; Revenue Drops to $4,000

Reuters
·
Aug 07

Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million

Reuters
·
Aug 07

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026

GlobeNewswire
·
Aug 07

Lyell Immunopharma, Inc. : Stifel Initiates Coverage with Buy Rating; Target Price $36

THOMSON REUTERS
·
Aug 06

Stifel Initiates Lyell Immunopharma at Buy With $36 Price Target

MT Newswires Live
·
Aug 06

Lyell Immunopharma initiated with a Buy at Stifel

TIPRANKS
·
Aug 06

B. Riley Initiates Lyell Immunopharma at Buy With $44 Price Target

MT Newswires Live
·
Jul 22